These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29102233)

  • 21. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
    Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response.
    Shwaartz C; Haim N; Rosin D; Lawrence Y; Gutman M; Zmora O
    Colorectal Dis; 2015 Jul; 17(7):595-9. PubMed ID: 25605475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive MR assessment of macroscopic and microscopic vascular abnormalities in the rectal tumour-surrounding mesorectum.
    Kluza E; Kleijnen JP; Martens MH; Rennspiess D; Maas M; Jeukens CR; Riedl RG; zur Hausen A; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 May; 26(5):1311-9. PubMed ID: 26318370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
    BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Kim SH; Lee JM; Gupta SN; Han JK; Choi BI
    J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative MRI assessment of mucinous rectal adenocarcinoma to predict tumour response after neoadjuvant therapy.
    Cao W; Li Z; Mohamoud A; Gong J; Wang X; Zhou J; Hu H; Huang Y; Li W; Li F; Liu D; Liang C; Zhou Z
    Clin Radiol; 2019 Apr; 74(4):278-286. PubMed ID: 30686505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
    Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
    Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
    Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer.
    Pham TT; Liney GP; Wong K; Barton MB
    Br J Radiol; 2017 Apr; 90(1072):20151078. PubMed ID: 28055248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
    Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the inferior mesenteric vein diameter as a surrogate marker to evaluate response to neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma.
    Ivan CV; Mullineux JH; Verma R; Shah V; De A; Elabassy M; Rajesh A; Stephenson JA
    Colorectal Dis; 2017 Dec; 19(12):1076-1080. PubMed ID: 28696522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy.
    Kalisz KR; Enzerra MD; Paspulati RM
    Radiographics; 2019; 39(2):538-556. PubMed ID: 30844347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
    Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
    Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.
    Bellomi M; Petralia G; Sonzogni A; Zampino MG; Rocca A
    Radiology; 2007 Aug; 244(2):486-93. PubMed ID: 17641369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
    Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
    Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.
    Intven M; Reerink O; Philippens ME
    J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of magnetic resonance imaging to diagnose pathological complete response of rectal cancer after therapy: A protocol for meta-analysis.
    Zhang M; Li J; Ma X; Wang B; Wu J; Gao Y; Tian J; Wang J
    Medicine (Baltimore); 2018 Oct; 97(43):e12901. PubMed ID: 30412091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.